Table 4.
ITT | |||
---|---|---|---|
TXA group (n = xx) | Standard care group (n = xx) | OR (95% CI) | |
Any SAE, n (%) | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Recurrent bleeding | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Hydrocephalus | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Delayed cerebral ischemia | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Thromboembolic complications during treatment Coiling, n (%) |
NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Infarct related to procedure Clipping, n (%) |
NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Procedural rupture Coiling, n (%) Clipping, n (%) |
NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Extracranial thrombosis | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
- DVT | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
- PE | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Hemorrhagic complication | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Severe hyponatremia | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Pneumonia | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Meningitis | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Urinary tract infection | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Epilepsy | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Delirium | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Terson’s syndrome | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
SUSARs | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
Other | NN (X) | NN (X) | X.XX (X.XX–X.XX) |
CI confidence interval, DVT deep venous thrombosis, ITT intention to treat, OR odds ratio, PE pulmonary embolism, SAE serious adverse event, SUSARs suspected unexpected serious adverse reactions, TXA tranexamic acid